candidate_genes,disease,celltype,y,user_question,full_query
"['PPM1L', 'PPIA', 'NIT1', 'CDK10', 'TMEM143']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,PPIA,"Which gene among PPM1L, PPIA, NIT1, CDK10, and TMEM143 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis?","Which gene among PPM1L, PPIA, NIT1, CDK10, and TMEM143 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis from the literature and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, retrieve the list of genes activated in effector memory CD4+ alpha-beta T cells from PINNACLE, and determine which of these overlap with the RA therapeutic targets. Using this overlapping set as the cell-type–specific targets for RA, compute their average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual target gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NMNAT1', 'ZNF574', 'RPL3', 'TMX3', 'ZNF713']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPL3,"Which gene among NMNAT1, ZNF574, RPL3, TMX3, and ZNF713 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells and may serve as the most promising target for rheumatoid arthritis therapy?","Which gene among NMNAT1, ZNF574, RPL3, TMX3, and ZNF713 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells and may serve as the most promising target for rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis from PINNACLE and extract their cell-type–specific embeddings. Determine which of these targets overlap with the effector memory CD4+ αβ T cell-activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this subset, then calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MBLAC1', 'ZNF454', 'LATS2-AS1', 'RPLP1', 'SCGB1C1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPLP1,"Which gene among MBLAC1, ZNF454, LATS2-AS1, RPLP1, and SCGB1C1 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis therapy?","Which gene among MBLAC1, ZNF454, LATS2-AS1, RPLP1, and SCGB1C1 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which effector memory CD4+ αβ T-cell genes in PINNACLE overlap with these targets, considering this overlapping set as the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this set and calculate the cosine similarity between that average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FOXI3', 'CORO1A', 'LINC02604', 'SRSF11', 'SLC30A5']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CORO1A,"Which gene, among FOXI3, CORO1A, LINC02604, SRSF11, and SLC30A5, exhibits the highest cell-type specificity for effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis therapy?","Which gene, among FOXI3, CORO1A, LINC02604, SRSF11, and SLC30A5, exhibits the highest cell-type specificity for effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis therapy? Identify established therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector memory CD4+ αβ T cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC30A7', 'TAFA1', 'CCDC186', 'DDX6', 'SZRD1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,DDX6,"Which gene among SLC30A7, TAFA1, CCDC186, DDX6, and SZRD1 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among SLC30A7, TAFA1, CCDC186, DDX6, and SZRD1 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which of these targets overlap with the effector memory CD4+ αβ T cell–activated gene embeddings in PINNACLE. Next, compute the average embedding for the overlapping set and calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF10', 'FAM81B', 'GPSM3', 'LRFN4', 'CRYBA4']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,GPSM3,"Which gene among ZNF10, FAM81B, GPSM3, LRFN4, and CRYBA4 exhibits the highest specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among ZNF10, FAM81B, GPSM3, LRFN4, and CRYBA4 exhibits the highest specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes – specifically those activated in effector memory CD4+ alpha–beta T cells – overlap with these targets, defining this overlapping set as the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of these targets as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the leading candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ZRANB2-AS1', 'TBC1D10C', 'S100A10', 'ZC3H12B', 'SAMD3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,S100A10,"Which gene among ZRANB2-AS1, TBC1D10C, S100A10, ZC3H12B, and SAMD3 exhibits the highest cell-type specificity in effector memory CD4+ alpha-beta T cells for targeting rheumatoid arthritis?","Which gene among ZRANB2-AS1, TBC1D10C, S100A10, ZC3H12B, and SAMD3 exhibits the highest cell-type specificity in effector memory CD4+ alpha-beta T cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which effector memory CD4+ αβ T cell–activated genes in PINNACLE overlap with these targets to define cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LSM2', 'SRI-AS1', 'LIMK2', 'NCRNA00250', 'COX4I1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,COX4I1,"Among the genes LSM2, SRI-AS1, LIMK2, NCRNA00250, and COX4I1, which exhibits the highest cell-type specificity in effector memory CD4⁺ αβ T cells, thereby representing the most promising candidate for therapeutic targeting in rheumatoid arthritis?","Among the genes LSM2, SRI-AS1, LIMK2, NCRNA00250, and COX4I1, which exhibits the highest cell-type specificity in effector memory CD4⁺ αβ T cells, thereby representing the most promising candidate for therapeutic targeting in rheumatoid arthritis? Identify and validate therapeutic targets for rheumatoid arthritis using the PINNACLE dataset by retrieving their cell-type–specific embeddings. Next, determine the overlap between these targets and the genes activated in effector memory CD4+ αβ T cells in PINNACLE to define a set of cell-type–specific RA targets. Compute the average embedding vector for this set, then calculate the cosine similarity between this reference vector and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADNP', 'CD2', 'C6orf226', 'ODC1-DT', 'ZBTB6']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD2,"Among the genes ADNP, CD2, C6orf226, ODC1-DT, and ZBTB6, which one exhibits the highest specificity for effector memory CD4+ alpha-beta T cells and represents the most promising candidate for targeting in rheumatoid arthritis?","Among the genes ADNP, CD2, C6orf226, ODC1-DT, and ZBTB6, which one exhibits the highest specificity for effector memory CD4+ alpha-beta T cells and represents the most promising candidate for targeting in rheumatoid arthritis? Identify verified rheumatoid arthritis therapeutic targets and obtain their cell-type–specific embeddings from PINNACLE. Next, intersect these targets with the list of genes activated in effector memory CD4+ αβ T cells from PINNACLE to define the cell-type–specific RA targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average embedding and each individual target. If one gene shows markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFT27', 'AMD1', 'CHDH', 'ZW10', 'TNFAIP3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,TNFAIP3,"Among the genes IFT27, AMD1, CHDH, ZW10, and TNFAIP3, which one exhibits the highest specificity for effector memory CD4⁺ αβ T cells in the context of rheumatoid arthritis?","Among the genes IFT27, AMD1, CHDH, ZW10, and TNFAIP3, which one exhibits the highest specificity for effector memory CD4⁺ αβ T cells in the context of rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the effector memory CD4+ alpha-beta T cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlap set, then calculate the cosine similarity between this average and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['DENND6A', 'CD3E', 'HES6', 'CPEB1-AS1', 'LILRB3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD3E,"Among DENND6A, CD3E, HES6, CPEB1-AS1, and LILRB3, which gene exhibits the highest specificity for effector memory CD4+ alpha-beta T cells in the context of rheumatoid arthritis targeting?","Among DENND6A, CD3E, HES6, CPEB1-AS1, and LILRB3, which gene exhibits the highest specificity for effector memory CD4+ alpha-beta T cells in the context of rheumatoid arthritis targeting? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the set of effector memory CD4+ αβ T cell-activated genes, defining this overlap as the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and each individual target gene. If one gene demonstrates a substantially higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['MILR1', 'VPS26B', 'LTB', 'PREB', 'CLCN7']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,LTB,"Among the genes MILR1, VPS26B, LTB, PREB, and CLCN7, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes MILR1, VPS26B, LTB, PREB, and CLCN7, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the effector memory CD4+ αβ T cell gene set in PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance in rheumatoid arthritis."
"['IL6ST', 'GALNT11', 'TTC1', 'TMEM141', 'AGO4']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,IL6ST,"Which of the following genes—IL6ST, GALNT11, TTC1, TMEM141, or AGO4—exhibits the highest cell-type specificity in effector memory CD4+ alpha-beta T cells for targeting rheumatoid arthritis?","Which of the following genes—IL6ST, GALNT11, TTC1, TMEM141, or AGO4—exhibits the highest cell-type specificity in effector memory CD4+ alpha-beta T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Then, from the set of effector memory CD4+ αβ T cell–expressed genes in PINNACLE, determine those that overlap with the RA targets. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average and each individual gene’s embedding. If one gene shows a markedly higher similarity compared with the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C16orf95', 'EML3', 'TMEM38A', 'CRIM1-DT', 'HLA-A']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,HLA-A,"Among the genes C16orf95, EML3, TMEM38A, CRIM1-DT, and HLA-A, which exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis therapy?","Among the genes C16orf95, EML3, TMEM38A, CRIM1-DT, and HLA-A, which exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis therapy? Identify the confirmed therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector memory CD4+ αβ T cell activation genes available in PINNACLE. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual gene. If one gene displays a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence‐based justification for its biological relevance."
"['CTBP1-AS', 'CCNYL1', 'CCDC196', 'MT-ND3', 'ELMOD3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,MT-ND3,"Among the genes CTBP1-AS, CCNYL1, CCDC196, MT-ND3, and ELMOD3, which one demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for targeted rheumatoid arthritis intervention?","Among the genes CTBP1-AS, CCNYL1, CCDC196, MT-ND3, and ELMOD3, which one demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for targeted rheumatoid arthritis intervention? Using verified rheumatoid arthritis therapeutic targets, retrieve their cell-type–specific embeddings from PINNACLE and compare them to the embeddings of effector memory CD4+ alpha beta T cell-activated genes in the database. Identify the overlapping genes between these two sets, calculate the average embedding for this overlapping group, and then compute the cosine similarity between the average embedding and each individual target's embedding. If one gene exhibits notably higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LINC01825', 'DDR1-DT', 'RUBCNL', 'CD52', 'GLIS2-AS1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD52,"Which gene among LINC01825, DDR1-DT, RUBCNL, CD52, and GLIS2-AS1 exhibits the highest specificity for effector memory CD4+ αβ T cells, thereby serving as the most promising candidate for targeted rheumatoid arthritis therapy?","Which gene among LINC01825, DDR1-DT, RUBCNL, CD52, and GLIS2-AS1 exhibits the highest specificity for effector memory CD4+ αβ T cells, thereby serving as the most promising candidate for targeted rheumatoid arthritis therapy? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell type–specific embeddings from PINNACLE. Then, determine which of the effector memory CD4+ alpha-beta T cell-activated genes overlap with these targets. Compute the average embedding of this overlapping set, calculate the cosine similarity between this reference embedding and each individual target’s embedding, and nominate as the top candidate the gene that exhibits a markedly higher similarity. Provide a concise, evidence-based rationale for its biological relevance."
"['NUDCD1', 'JAK3', 'HMGCS1', 'CDC45', 'TRBV23-1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,JAK3,"Which gene among NUDCD1, JAK3, HMGCS1, CDC45, and TRBV23-1 shows the highest specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among NUDCD1, JAK3, HMGCS1, CDC45, and TRBV23-1 shows the highest specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector memory CD4+ αβ T cell-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STX5', 'RPL21', 'CHMP6', 'EMSLR', 'C18orf21']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPL21,"Which gene among STX5, RPL21, CHMP6, EMSLR, and C18orf21 demonstrates the highest specificity in effector memory CD4+ αβ T cells, thereby emerging as the most promising candidate target for rheumatoid arthritis treatment?","Which gene among STX5, RPL21, CHMP6, EMSLR, and C18orf21 demonstrates the highest specificity in effector memory CD4+ αβ T cells, thereby emerging as the most promising candidate target for rheumatoid arthritis treatment? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in effector memory CD4+ αβ T cells (as defined by PINNACLE) overlap with these targets. For these overlapping genes, calculate the average embedding, then compute the cosine similarity between this average and the individual gene embeddings. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a succinct, evidence-based explanation for its biological relevance."
"['CORO1C', 'GUCY1A2', 'PRDM1', 'ADAMTS6', 'RIPOR3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,PRDM1,"Which gene among CORO1C, GUCY1A2, PRDM1, ADAMTS6, and RIPOR3 demonstrates the highest cell-type specificity in effector memory CD4+ alpha-beta T cells associated with rheumatoid arthritis?","Which gene among CORO1C, GUCY1A2, PRDM1, ADAMTS6, and RIPOR3 demonstrates the highest cell-type specificity in effector memory CD4+ alpha-beta T cells associated with rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and genes activated in effector memory CD4+ alpha-beta T cells within PINNACLE, thereby defining the cell-type–specific therapeutic targets for rheumatoid arthritis. Compute the average embedding of this overlapping set to serve as a reference profile, then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FABP6-AS1', 'C12orf40', 'RELCH', 'DDR1-DT', 'HLA-C']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,HLA-C,"Which gene among FABP6-AS1, C12orf40, RELCH, DDR1-DT, and HLA-C shows the greatest specificity for effector memory CD4⁺ αβ T cells in the context of targeting rheumatoid arthritis?","Which gene among FABP6-AS1, C12orf40, RELCH, DDR1-DT, and HLA-C shows the greatest specificity for effector memory CD4⁺ αβ T cells in the context of targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. From the effector memory CD4+ αβ T cell activation gene set in PINNACLE, identify the genes that overlap with these targets. Calculate the average embedding of the overlapping genes and compute the cosine similarity of each individual target’s embedding relative to this average. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF662', 'ETHE1', 'HDGFL2', 'HLA-E', 'KLF12']",rheumatoid arthritis,classical monocyte,HLA-E,"Which gene—ZNF662, ETHE1, HDGFL2, HLA-E, or KLF12—exhibits the highest cell-type specificity in classical monocytes for a potential rheumatoid arthritis target?","Which gene—ZNF662, ETHE1, HDGFL2, HLA-E, or KLF12—exhibits the highest cell-type specificity in classical monocytes for a potential rheumatoid arthritis target? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which classical monocyte-activated genes identified in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['SCMH1', 'CDCA5', 'VAMP2', 'EFNB1', 'ZEB2']",rheumatoid arthritis,classical monocyte,ZEB2,"Which gene among SCMH1, CDCA5, VAMP2, EFNB1, and ZEB2 exhibits the highest cell-type specificity in classical monocytes as a potential target in rheumatoid arthritis?","Which gene among SCMH1, CDCA5, VAMP2, EFNB1, and ZEB2 exhibits the highest cell-type specificity in classical monocytes as a potential target in rheumatoid arthritis? Determine the validated therapeutic targets for rheumatoid arthritis and extract their cell type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the classical monocyte-activated genes in PINNACLE to define a set of cell type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the individual gene embeddings. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a brief, evidence-based rationale for its relevance to rheumatoid arthritis."
"['F13A1', 'RETREG2', 'IL1B', 'ZNF33B', 'PYROXD2']",rheumatoid arthritis,classical monocyte,IL1B,"Which gene among F13A1, RETREG2, IL1B, ZNF33B, and PYROXD2 exhibits the highest specificity in classical monocytes associated with rheumatoid arthritis?","Which gene among F13A1, RETREG2, IL1B, ZNF33B, and PYROXD2 exhibits the highest specificity in classical monocytes associated with rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis that have cell-type–specific embeddings in the PINNACLE database and determine which of these targets overlap with classical monocyte-activated genes. Calculate the average embedding of the overlapping targets and compute the cosine similarity between this average and each individual target embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TEX29', 'RBM5-AS1', 'CPEB3', 'CDC42EP3', 'ZNF699']",rheumatoid arthritis,classical monocyte,CDC42EP3,"Which gene among TEX29, RBM5-AS1, CPEB3, CDC42EP3, and ZNF699 exhibits the highest specificity in classical monocytes for its association with rheumatoid arthritis?","Which gene among TEX29, RBM5-AS1, CPEB3, CDC42EP3, and ZNF699 exhibits the highest specificity in classical monocytes for its association with rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE, as this overlap defines the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set, calculate the cosine similarity between this average and each individual target's embedding, and, if one gene exhibits significantly higher similarity than the others, nominate it as the top candidate. Provide a brief, evidence-based explanation for its biological relevance."
"['SPACA6', 'ADAM17', 'ATXN2L', 'METTL15', 'FAF1']",rheumatoid arthritis,classical monocyte,ADAM17,"Which gene—SPACA6, ADAM17, ATXN2L, METTL15, or FAF1—exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis?","Which gene—SPACA6, ADAM17, ATXN2L, METTL15, or FAF1—exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE. For the overlapping genes, compute their average embedding to serve as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IAPP', 'WDR25', 'AHR', 'HEATR1', 'HSPB9']",rheumatoid arthritis,classical monocyte,AHR,"Among the genes IAPP, WDR25, AHR, HEATR1, and HSPB9, which shows the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Among the genes IAPP, WDR25, AHR, HEATR1, and HSPB9, which shows the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference embedding and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HIF1A', 'TLK1', 'DCST1', 'UBE2H', 'MAST4']",rheumatoid arthritis,classical monocyte,HIF1A,"Which gene among HIF1A, TLK1, DCST1, UBE2H, and MAST4 exhibits the highest classical monocyte-specific expression in the context of rheumatoid arthritis?","Which gene among HIF1A, TLK1, DCST1, UBE2H, and MAST4 exhibits the highest classical monocyte-specific expression in the context of rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the classical monocyte-activated genes contained in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference profile and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PMF1', 'SYT12', 'APBB1', 'TLE3', 'FRYL']",rheumatoid arthritis,classical monocyte,TLE3,"Among the genes PMF1, SYT12, APBB1, TLE3, and FRYL, which one exhibits the greatest specificity in classical monocytes and represents the most promising candidate for targeting rheumatoid arthritis?","Among the genes PMF1, SYT12, APBB1, TLE3, and FRYL, which one exhibits the greatest specificity in classical monocytes and represents the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the classical monocyte-activated genes in PINNACLE, which will define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this set and calculate the cosine similarity between the average and each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate, supporting your choice with a concise, evidence-based explanation of its biological significance."
"['PRKD3', 'LINC02319', 'IPMK', 'IFNGR2', 'TACR1']",rheumatoid arthritis,classical monocyte,IFNGR2,"Which gene among PRKD3, LINC02319, IPMK, IFNGR2, and TACR1 exhibits the highest cell-type specificity in classical monocytes as a potential target for rheumatoid arthritis intervention?","Which gene among PRKD3, LINC02319, IPMK, IFNGR2, and TACR1 exhibits the highest cell-type specificity in classical monocytes as a potential target for rheumatoid arthritis intervention? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the classical monocyte-activated genes in PINNACLE to define cell-type–specific rheumatoid arthritis targets. Compute the average embedding for this overlapping set as a reference point, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['POLR3C', 'FER1L5', 'CHMP6', 'ARFGAP1', 'HLA-DRA']",rheumatoid arthritis,classical monocyte,HLA-DRA,"Among the genes POLR3C, FER1L5, CHMP6, ARFGAP1, and HLA-DRA, which exhibits the highest specificity in classical monocytes, making it the most promising candidate for targeted rheumatoid arthritis therapy?","Among the genes POLR3C, FER1L5, CHMP6, ARFGAP1, and HLA-DRA, which exhibits the highest specificity in classical monocytes, making it the most promising candidate for targeted rheumatoid arthritis therapy? Identify and verify the therapeutic targets for rheumatoid arthritis, and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the genes associated with classical monocyte activation in PINNACLE. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NFKBIA', 'ANKRD36C', 'CCND3', 'SETDB1', 'TRA2A']",rheumatoid arthritis,classical monocyte,NFKBIA,"Which gene among NFKBIA, ANKRD36C, CCND3, SETDB1, and TRA2A demonstrates the highest cell-type-specific expression in classical monocytes in the context of rheumatoid arthritis?","Which gene among NFKBIA, ANKRD36C, CCND3, SETDB1, and TRA2A demonstrates the highest cell-type-specific expression in classical monocytes in the context of rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in classical monocytes within PINNACLE. For the overlapping gene set, compute the average embedding and then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SASS6', 'RPLP1', 'NDUFAF7', 'CRYBG2', 'KCNH1']",rheumatoid arthritis,classical monocyte,RPLP1,"Which gene among SASS6, RPLP1, NDUFAF7, CRYBG2, and KCNH1 demonstrates the greatest cell-type specificity in classical monocytes, making it the most promising candidate for targeting in rheumatoid arthritis?","Which gene among SASS6, RPLP1, NDUFAF7, CRYBG2, and KCNH1 demonstrates the greatest cell-type specificity in classical monocytes, making it the most promising candidate for targeting in rheumatoid arthritis? Identify and validate the therapeutic targets for rheumatoid arthritis using PINNACLE by retrieving their cell-type–specific embeddings. Next, intersect these targets with the set of classical monocyte-activated genes defined in PINNACLE. Compute the average embedding of this overlapping gene set to establish a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FLJ20021', 'MTPAP', 'DFFB', 'ABCE1', 'KTN1']",rheumatoid arthritis,classical monocyte,MTPAP,"Among the genes FLJ20021, MTPAP, DFFB, ABCE1, and KTN1, which one exhibits the highest cell-type specificity in classical monocytes, thereby representing the strongest candidate for targeting rheumatoid arthritis?","Among the genes FLJ20021, MTPAP, DFFB, ABCE1, and KTN1, which one exhibits the highest cell-type specificity in classical monocytes, thereby representing the strongest candidate for targeting rheumatoid arthritis? Identify confirmed therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with classical monocyte-activated genes in PINNACLE to define cell-type–specific rheumatoid arthritis targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['HIF1A', 'ANKRD31', 'ZW10', 'ATRNL1', 'FOXP4-AS1']",rheumatoid arthritis,classical monocyte,HIF1A,"Which gene among HIF1A, ANKRD31, ZW10, ATRNL1, and FOXP4-AS1 demonstrates the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Which gene among HIF1A, ANKRD31, ZW10, ATRNL1, and FOXP4-AS1 demonstrates the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis using cell-type–specific embeddings from the PINNACLE resource. Next, compare these targets with the set of classical monocyte-activated genes and identify the overlapping genes to establish a list of cell-type–specific targets. Calculate the average embedding of these targets and then compute the cosine similarity between this reference embedding and each individual target's embedding. Finally, if one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DGUOK', 'HYOU1', 'LINC00310', 'CDC42EP3', 'MPI']",rheumatoid arthritis,classical monocyte,CDC42EP3,"Which gene among DGUOK, HYOU1, LINC00310, CDC42EP3, and MPI exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Which gene among DGUOK, HYOU1, LINC00310, CDC42EP3, and MPI exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis (RA) and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the subset that overlaps with classical monocyte-activated genes, representing cell-type-specific RA targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UBAP1L', 'TLE3', 'PIK3CB', 'LINC01376', 'IGHV3-33']",rheumatoid arthritis,classical monocyte,TLE3,"Among the genes UBAP1L, TLE3, PIK3CB, LINC01376, and IGHV3-33, which one exhibits the highest specificity of expression in classical monocytes and represents the most promising candidate for targeted intervention in rheumatoid arthritis?","Among the genes UBAP1L, TLE3, PIK3CB, LINC01376, and IGHV3-33, which one exhibits the highest specificity of expression in classical monocytes and represents the most promising candidate for targeted intervention in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE. Compute the average embedding for this overlapping group and calculate the cosine similarity between this average and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RIPOR3', 'RALGAPB', 'ADAM17', 'TRAV5', 'ANKS4B']",rheumatoid arthritis,classical monocyte,ADAM17,"Which gene among RIPOR3, RALGAPB, ADAM17, TRAV5, and ANKS4B exhibits the highest specificity in classical monocytes for targeting rheumatoid arthritis?","Which gene among RIPOR3, RALGAPB, ADAM17, TRAV5, and ANKS4B exhibits the highest specificity in classical monocytes for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes from the classical monocyte activation set in PINNACLE overlap with these targets, and compute the average embedding of the overlapping set. Calculate the cosine similarity between this average embedding and the embedding of each overlapping gene. If one gene exhibits a significantly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TARBP1', 'LINC00663', 'CDT1', 'GPX2', 'HLA-E']",rheumatoid arthritis,classical monocyte,HLA-E,"Among the genes TARBP1, LINC00663, CDT1, GPX2, and HLA-E, which one exhibits the highest cell-type specificity in classical monocytes relevant to rheumatoid arthritis targeting?","Among the genes TARBP1, LINC00663, CDT1, GPX2, and HLA-E, which one exhibits the highest cell-type specificity in classical monocytes relevant to rheumatoid arthritis targeting? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the classical monocyte-activated genes in PINNACLE. For the overlapping set, calculate the average embedding to serve as a reference and then compute the cosine similarity between this reference and each gene’s individual embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CSMD1', 'PHLDA3', 'SEMA3F', 'LIMD2', 'HLA-DRA']",rheumatoid arthritis,classical monocyte,HLA-DRA,"Among the genes CSMD1, PHLDA3, SEMA3F, LIMD2, and HLA-DRA, which one exhibits the highest expression specificity in classical monocytes, making it the most promising candidate for targeted rheumatoid arthritis intervention?","Among the genes CSMD1, PHLDA3, SEMA3F, LIMD2, and HLA-DRA, which one exhibits the highest expression specificity in classical monocytes, making it the most promising candidate for targeted rheumatoid arthritis intervention? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the classical monocyte-activated genes in PINNACLE, and compute the average embedding of this overlapping set. Calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['NFKBIA', 'USP39', 'CD82', 'EHD4-AS1', 'SPOP']",rheumatoid arthritis,classical monocyte,NFKBIA,"Among NFKBIA, USP39, CD82, EHD4-AS1, and SPOP, which gene shows the highest cell-type specificity in classical monocytes, making it the most promising target for rheumatoid arthritis intervention?","Among NFKBIA, USP39, CD82, EHD4-AS1, and SPOP, which gene shows the highest cell-type specificity in classical monocytes, making it the most promising target for rheumatoid arthritis intervention? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE. For the overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CCP110', 'FOS', 'CCN3', 'SF3B1', 'SUSD4']",rheumatoid arthritis,naive b cell,FOS,"Which gene among CCP110, FOS, CCN3, SF3B1, and SUSD4 exhibits the highest cell-type specificity in naive B cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among CCP110, FOS, CCN3, SF3B1, and SUSD4 exhibits the highest cell-type specificity in naive B cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embedding profiles from the PINNACLE database. Next, determine which targets overlap with the set of naive B cell–activated genes in PINNACLE, defining these as the cell-specific RA targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HERPUD2', 'MT-ND3', 'FAM241B', 'SV2A', 'ZSCAN22']",rheumatoid arthritis,naive b cell,MT-ND3,"Among the genes HERPUD2, MT-ND3, FAM241B, SV2A, and ZSCAN22, which one exhibits the highest cell-type specificity in naive B cells as a potential target for rheumatoid arthritis treatment?","Among the genes HERPUD2, MT-ND3, FAM241B, SV2A, and ZSCAN22, which one exhibits the highest cell-type specificity in naive B cells as a potential target for rheumatoid arthritis treatment? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets are present among the naive B cell–activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping gene set and compute the cosine similarity between this average and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GMFB', 'PDXK', 'FCHSD2', 'YPEL5', 'ERVK3-1']",rheumatoid arthritis,naive b cell,YPEL5,"Among the candidate genes GMFB, PDXK, FCHSD2, YPEL5, and ERVK3-1, which exhibits the highest cell-type specificity in naive B cells, thereby representing the most promising target for rheumatoid arthritis intervention?","Among the candidate genes GMFB, PDXK, FCHSD2, YPEL5, and ERVK3-1, which exhibits the highest cell-type specificity in naive B cells, thereby representing the most promising target for rheumatoid arthritis intervention? Using validated therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from PINNACLE. Identify which naive B cell–activated genes overlap with these targets to define the cell-type–specific target set. Compute the average embedding for this set as a reference profile, and then calculate the cosine similarity between the reference and each target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MST1R', 'NFKBIA', 'CCT3', 'ZNF594-DT', 'BCAR3-AS1']",rheumatoid arthritis,naive b cell,NFKBIA,"Among the genes MST1R, NFKBIA, CCT3, ZNF594-DT, and BCAR3-AS1, which shows the highest cell-type specificity in naive B cells and is the most promising candidate for targeting in rheumatoid arthritis?","Among the genes MST1R, NFKBIA, CCT3, ZNF594-DT, and BCAR3-AS1, which shows the highest cell-type specificity in naive B cells and is the most promising candidate for targeting in rheumatoid arthritis? Retrieve the established therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which of these targets intersect with the naive B cell–activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping set as a reference profile, then determine the cosine similarity between this reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CXXC5-AS1', 'RNF32-AS1', 'SLAMF9', 'RPS26', 'LINC00115']",rheumatoid arthritis,naive b cell,RPS26,"Among the genes CXXC5-AS1, RNF32-AS1, SLAMF9, RPS26, and LINC00115, which exhibits the highest specificity for naive B cells and is therefore the most promising candidate target for rheumatoid arthritis?","Among the genes CXXC5-AS1, RNF32-AS1, SLAMF9, RPS26, and LINC00115, which exhibits the highest specificity for naive B cells and is therefore the most promising candidate target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of the naive B cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type-specific rheumatoid arthritis targets. Calculate the average embedding of this overlapping set as a reference, and compute the cosine similarity between this reference and each individual target's embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CHKB', 'FLJ13224', 'NANOGNB', 'MTM1', 'MS4A1']",rheumatoid arthritis,naive b cell,MS4A1,"Among the genes CHKB, FLJ13224, NANOGNB, MTM1, and MS4A1, which one demonstrates the most specific expression in naive B cells and is the best candidate for targeted intervention in rheumatoid arthritis?","Among the genes CHKB, FLJ13224, NANOGNB, MTM1, and MS4A1, which one demonstrates the most specific expression in naive B cells and is the best candidate for targeted intervention in rheumatoid arthritis? Using validated therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from PINNACLE. Then, identify which of the naive B cell–activated genes in PINNACLE overlap with these targets to form a subset of cell-type–specific therapeutic candidates. Compute the average embedding of this subset as a reference point, and calculate the cosine similarity between this reference and each gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LINC02478', 'MIR29B2CHG', 'TTI1', 'CASK', 'IRF1']",rheumatoid arthritis,naive b cell,IRF1,"Among the genes LINC02478, MIR29B2CHG, TTI1, CASK, and IRF1, which one exhibits the highest degree of cell-type-specific expression in naive B cells, thereby representing the most promising candidate target for rheumatoid arthritis?","Among the genes LINC02478, MIR29B2CHG, TTI1, CASK, and IRF1, which one exhibits the highest degree of cell-type-specific expression in naive B cells, thereby representing the most promising candidate target for rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the gene set associated with naive B cell activation in PINNACLE, thereby defining the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping gene set and then compute the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['THOC7', 'CCDC65', 'NFKBIA', 'RGL3', 'GPR42']",rheumatoid arthritis,naive b cell,NFKBIA,"Among THOC7, CCDC65, NFKBIA, RGL3, and GPR42, which gene exhibits the most specific expression in naive B cells and thereby represents the most promising target for rheumatoid arthritis?","Among THOC7, CCDC65, NFKBIA, RGL3, and GPR42, which gene exhibits the most specific expression in naive B cells and thereby represents the most promising target for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the naive B cell activation gene set in PINNACLE, forming the cell-type–specific target subset. Calculate the average embedding for this subset and then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['BAIAP2-DT', 'RAX2', 'KRT2', 'RPS26', 'AHCY']",rheumatoid arthritis,naive b cell,RPS26,"Among the genes BAIAP2-DT, RAX2, KRT2, RPS26, and AHCY, which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Among the genes BAIAP2-DT, RAX2, KRT2, RPS26, and AHCY, which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the naive B cell–activated genes in PINNACLE to define the cell-type–specific RA targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target. If a single gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['ITGA10', 'KCNJ2', 'LINC01882', 'RILPL1', 'FOS']",rheumatoid arthritis,naive b cell,FOS,"Among ITGA10, KCNJ2, LINC01882, RILPL1, and FOS, which gene exhibits the highest cell-type specificity in naive B cells, making it the most promising candidate for targeting rheumatoid arthritis?","Among ITGA10, KCNJ2, LINC01882, RILPL1, and FOS, which gene exhibits the highest cell-type specificity in naive B cells, making it the most promising candidate for targeting rheumatoid arthritis? Collect the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the naive B cell activation genes in PINNACLE. For the overlapping genes, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['TRPC5', 'DHFR2', 'MT-ND3', 'RAD51C', 'LINC02267']",rheumatoid arthritis,naive b cell,MT-ND3,"Among TRPC5, DHFR2, MT-ND3, RAD51C, and LINC02267, which gene demonstrates the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Among TRPC5, DHFR2, MT-ND3, RAD51C, and LINC02267, which gene demonstrates the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Using the verified therapeutic targets for rheumatoid arthritis, obtain their cell-type–specific embeddings from PINNACLE. Identify the overlapping genes between these targets and the naive B cell–activated genes available in PINNACLE, defining this overlap as the cell-type–specific targets for rheumatoid arthritis. Next, compute the average embedding for this set and calculate the cosine similarity between this average and each individual target. If one gene shows a substantially higher similarity than all others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological significance in rheumatoid arthritis."
"['BCKDHA', 'IRF1', 'PCNP', 'SMIM33', 'LINC01931']",rheumatoid arthritis,naive b cell,IRF1,"Among the genes BCKDHA, IRF1, PCNP, SMIM33, and LINC01931, which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Among the genes BCKDHA, IRF1, PCNP, SMIM33, and LINC01931, which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive B cell–activated genes in PINNACLE to define a set of candidate cell-type–specific targets. Calculate the average embedding for this candidate set and then compute the cosine similarity between this reference embedding and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PPP2CB', 'LRP1', 'SLC17A9', 'YPEL5', 'CAPN10-DT']",rheumatoid arthritis,naive b cell,YPEL5,"Among the candidate genes PPP2CB, LRP1, SLC17A9, YPEL5, and CAPN10-DT, which exhibits the highest cell-type specificity in naive B cells for potential targeting in rheumatoid arthritis?","Among the candidate genes PPP2CB, LRP1, SLC17A9, YPEL5, and CAPN10-DT, which exhibits the highest cell-type specificity in naive B cells for potential targeting in rheumatoid arthritis? Using validated therapeutic targets for rheumatoid arthritis, retrieve their cell-type-specific embeddings from PINNACLE. Identify the targets that overlap with the set of naive B cell–activated genes in PINNACLE; this overlapping group defines the cell-type-specific RA targets. Calculate the average embedding for these genes, then compute the cosine similarity between each individual target’s embedding and this average. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BSDC1', 'MS4A1', 'ADGRA3', 'TRBV4-1', 'PRDM6']",rheumatoid arthritis,naive b cell,MS4A1,"Which gene among BSDC1, MS4A1, ADGRA3, TRBV4-1, and PRDM6 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among BSDC1, MS4A1, ADGRA3, TRBV4-1, and PRDM6 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Using PINNACLE, identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings. Then, determine which of these targets overlap with the set of naive B cell–activated genes in PINNACLE, designating this intersection as the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of these targets as a reference vector and calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['COQ4', 'NFKBIA', 'NUTM2D', 'DEK', 'TBL3']",rheumatoid arthritis,naive b cell,NFKBIA,"Among COQ4, NFKBIA, NUTM2D, DEK, and TBL3, which gene exhibits the highest expression specificity in naive B cells, making it the best candidate for targeting rheumatoid arthritis?","Among COQ4, NFKBIA, NUTM2D, DEK, and TBL3, which gene exhibits the highest expression specificity in naive B cells, making it the best candidate for targeting rheumatoid arthritis? Using PINNACLE, identify all verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings. Next, determine the intersection between these targets and the set of naive B cell-activated genes available in PINNACLE. For the overlapping genes, compute the average embedding as a reference, and then calculate the cosine similarity between this average and each individual embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['MT-ND3', 'VSIG10L', 'VPS16', 'MAPRE3', 'SH3GLB2']",rheumatoid arthritis,naive b cell,MT-ND3,"Which gene among MT-ND3, VSIG10L, VPS16, MAPRE3, and SH3GLB2 exhibits the highest cell-type specificity in naive B cells relevant for rheumatoid arthritis targeting?","Which gene among MT-ND3, VSIG10L, VPS16, MAPRE3, and SH3GLB2 exhibits the highest cell-type specificity in naive B cells relevant for rheumatoid arthritis targeting? Using the verified therapeutic targets for rheumatoid arthritis, retrieve their corresponding cell-type–specific embeddings from the PINNACLE dataset. Identify which targets overlap with the naive B cell-activated genes in PINNACLE to define the cell-type–specific targets for RA. Calculate the average embedding for these overlapping genes as a reference, then compute the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['TMEM272', 'RUVBL1', 'LINC00449', 'FOS', 'TBC1D19']",rheumatoid arthritis,naive b cell,FOS,"Which gene among TMEM272, RUVBL1, LINC00449, FOS, and TBC1D19 demonstrates the highest cell-type specificity in naive B cells as a potential target for rheumatoid arthritis?","Which gene among TMEM272, RUVBL1, LINC00449, FOS, and TBC1D19 demonstrates the highest cell-type specificity in naive B cells as a potential target for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the naive B cell-activated genes in PINNACLE overlap with these targets to create a cell-type–specific set. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual gene embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PI4KB', 'HTR3E-AS1', 'IRF1', 'BTBD19', 'IQCD']",rheumatoid arthritis,naive b cell,IRF1,"Among the genes PI4KB, HTR3E-AS1, IRF1, BTBD19, and IQCD, which exhibits the highest cell-type specificity in naive B cells relevant to rheumatoid arthritis targeting?","Among the genes PI4KB, HTR3E-AS1, IRF1, BTBD19, and IQCD, which exhibits the highest cell-type specificity in naive B cells relevant to rheumatoid arthritis targeting? Using the PINNACLE dataset, identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type-specific embeddings. Next, determine which of these targets overlap with the embeddings of naive B cell-activated genes. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the primary candidate, providing a concise, evidence-based rationale for its biological relevance."
"['SEC63', 'MYH3', 'SDHAF2', 'ODAD2', 'YPEL5']",rheumatoid arthritis,naive b cell,YPEL5,"Among the following genes—SEC63, MYH3, SDHAF2, ODAD2, and YPEL5—which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Among the following genes—SEC63, MYH3, SDHAF2, ODAD2, and YPEL5—which one exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in naive B cells from PINNACLE overlap with these targets—defining these as the cell-type–specific RA targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-supported justification for its biological relevance."
"['MS4A1', 'TNFAIP1', 'ELP6', 'ASB9', 'RECQL5']",rheumatoid arthritis,naive b cell,MS4A1,"Among MS4A1, TNFAIP1, ELP6, ASB9, and RECQL5, which gene demonstrates the highest cell-type specificity in naive B cells as a target for rheumatoid arthritis therapy?","Among MS4A1, TNFAIP1, ELP6, ASB9, and RECQL5, which gene demonstrates the highest cell-type specificity in naive B cells as a target for rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, intersect these targets with the set of naive B cell-activated genes in PINNACLE to obtain cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set as a reference and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['PIAS4', 'PRND', 'ZNF653', 'LTB', 'MOCS3']",rheumatoid arthritis,myeloid dendritic cell,LTB,"Among the genes PIAS4, PRND, ZNF653, LTB, and MOCS3, which exhibits the greatest specificity for myeloid dendritic cells, making it the most promising candidate for therapeutic targeting in rheumatoid arthritis?","Among the genes PIAS4, PRND, ZNF653, LTB, and MOCS3, which exhibits the greatest specificity for myeloid dendritic cells, making it the most promising candidate for therapeutic targeting in rheumatoid arthritis? Identify the established therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the myeloid dendritic cell-activated genes in PINNACLE. Calculate the average embedding for this overlapping set as a reference and then compute the cosine similarity between this reference and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC02594', 'RPL3', 'MOBP', 'CNNM1', 'C6orf58']",rheumatoid arthritis,myeloid dendritic cell,RPL3,"Among the genes LINC02594, RPL3, MOBP, CNNM1, and C6orf58, which one exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes LINC02594, RPL3, MOBP, CNNM1, and C6orf58, which one exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Which verified rheumatoid arthritis therapeutic targets in the PINNACLE dataset overlap with genes activated in myeloid dendritic cells? For these overlapping targets, compute their average cell-type–specific embedding and then determine the cosine similarity between this average embedding and each individual target embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['POLR2M', 'B3GALNT1', 'BCL2L13', 'GABRB1', 'ACTB']",rheumatoid arthritis,myeloid dendritic cell,ACTB,"Among the genes POLR2M, B3GALNT1, BCL2L13, GABRB1, and ACTB, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis therapy?","Among the genes POLR2M, B3GALNT1, BCL2L13, GABRB1, and ACTB, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis therapy? Which verified therapeutic targets for rheumatoid arthritis from PINNACLE have cell-type–specific embeddings, and which of these overlap with genes activated in myeloid dendritic cells? Compute the average embedding of the overlapping genes, then determine the cosine similarity between this average and each individual target embedding. Identify the gene with a markedly higher similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TSIX', 'IER3-AS1', 'RPS26', 'FAM200B', 'TRAPPC4']",rheumatoid arthritis,myeloid dendritic cell,RPS26,"Which gene among TSIX, IER3-AS1, RPS26, FAM200B, and TRAPPC4 exhibits the highest cell-type specificity in myeloid dendritic cells for rheumatoid arthritis targeting?","Which gene among TSIX, IER3-AS1, RPS26, FAM200B, and TRAPPC4 exhibits the highest cell-type specificity in myeloid dendritic cells for rheumatoid arthritis targeting? Identify the confirmed therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with genes activated in myeloid dendritic cells in PINNACLE. Calculate the average embedding of these overlapping genes to serve as a reference, compute the cosine similarity between this reference and each individual gene, and if one gene shows a markedly higher similarity than the others, nominate it as the top candidate. Provide a concise, evidence-based rationale for its biological relevance."
"['CARS1-AS1', 'VMAC', 'CD52', 'PGLS-DT', 'ZBED6']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Among the genes CARS1-AS1, VMAC, CD52, PGLS-DT, and ZBED6, which one exhibits the highest cell-type specificity in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy?","Among the genes CARS1-AS1, VMAC, CD52, PGLS-DT, and ZBED6, which one exhibits the highest cell-type specificity in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy? Identify verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in myeloid dendritic cells. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PAK3', 'HLA-E', 'SOCS6', 'CCT6A', 'SSTR2']",rheumatoid arthritis,myeloid dendritic cell,HLA-E,"Among the genes PAK3, HLA-E, SOCS6, CCT6A, and SSTR2, which exhibits the most specific expression in myeloid dendritic cells, making it the best candidate for targeted intervention in rheumatoid arthritis?","Among the genes PAK3, HLA-E, SOCS6, CCT6A, and SSTR2, which exhibits the most specific expression in myeloid dendritic cells, making it the best candidate for targeted intervention in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, determine the intersection between these targets and the genes activated in myeloid dendritic cells as represented in PINNACLE, defining the cell-specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CISD3', 'LINC01376', 'RPL21', 'JDP2', 'TAFA1']",rheumatoid arthritis,myeloid dendritic cell,RPL21,"Among the genes CISD3, LINC01376, RPL21, JDP2, and TAFA1, which one exhibits the highest cell-type-specific expression in myeloid dendritic cells for therapeutic targeting in rheumatoid arthritis?","Among the genes CISD3, LINC01376, RPL21, JDP2, and TAFA1, which one exhibits the highest cell-type-specific expression in myeloid dendritic cells for therapeutic targeting in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embedding data from PINNACLE. Next, determine which of the myeloid dendritic cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference vector and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its relevance in rheumatoid arthritis."
"['DRICH1', 'ZDHHC9', 'GTPBP2', 'RPLP1', 'LINC01772']",rheumatoid arthritis,myeloid dendritic cell,RPLP1,"Among the genes DRICH1, ZDHHC9, GTPBP2, RPLP1, and LINC01772, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes DRICH1, ZDHHC9, GTPBP2, RPLP1, and LINC01772, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the myeloid dendritic cell-activated genes in PINNACLE to define the set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['COX4I1', 'SIMC1', 'TENM4', 'SMAP1', 'HPS3']",rheumatoid arthritis,myeloid dendritic cell,COX4I1,"Among the genes COX4I1, SIMC1, TENM4, SMAP1, and HPS3, which one demonstrates the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes COX4I1, SIMC1, TENM4, SMAP1, and HPS3, which one demonstrates the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the subset of myeloid dendritic cell-activated genes in PINNACLE that overlaps with these targets, constituting the cell-type–specific rheumatoid arthritis targets. Calculate the average embedding of this set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene demonstrates a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CALM2', 'CHST10', 'CD52', 'ASB9', 'ITCH']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Among CALM2, CHST10, CD52, ASB9, and ITCH, which gene exhibits the highest specificity in myeloid dendritic cells for potential targeted therapy in rheumatoid arthritis?","Among CALM2, CHST10, CD52, ASB9, and ITCH, which gene exhibits the highest specificity in myeloid dendritic cells for potential targeted therapy in rheumatoid arthritis? Identify the validated therapeutic target genes for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these genes overlap with the myeloid dendritic cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Next, compute the average embedding of this set as a reference and calculate the cosine similarity between the reference and each gene's embedding. Finally, if one gene shows a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIF13A', 'SPAG17', 'RPL21', 'TPPP', 'ATIC']",rheumatoid arthritis,myeloid dendritic cell,RPL21,"Which gene among KIF13A, SPAG17, RPL21, TPPP, and ATIC exhibits the most specific expression in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis treatment?","Which gene among KIF13A, SPAG17, RPL21, TPPP, and ATIC exhibits the most specific expression in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis treatment? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which targets overlap with genes activated in myeloid dendritic cells in PINNACLE. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity of each target’s embedding to this reference. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABHD12B', 'SLK', 'RPL3', 'CEP72', 'WDR26']",rheumatoid arthritis,myeloid dendritic cell,RPL3,"Among the genes ABHD12B, SLK, RPL3, CEP72, and WDR26, which one exhibits the highest cell-type specificity in myeloid dendritic cells and represents the most promising target for rheumatoid arthritis intervention?","Among the genes ABHD12B, SLK, RPL3, CEP72, and WDR26, which one exhibits the highest cell-type specificity in myeloid dendritic cells and represents the most promising target for rheumatoid arthritis intervention? Determine the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Identify the genes activated in myeloid dendritic cells within PINNACLE that overlap with these targets, defining the cell-type–specific therapeutic set. Calculate the average embedding for these overlapping genes as a reference and then compute the cosine similarity between this reference and each target’s embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IDS', 'TRBV18', 'CCDC22', 'RPS26', 'MTUS2-AS1']",rheumatoid arthritis,myeloid dendritic cell,RPS26,"Among the genes IDS, TRBV18, CCDC22, RPS26, and MTUS2-AS1, which one exhibits the highest specificity for myeloid dendritic cells, thereby representing the most promising target for rheumatoid arthritis intervention?","Among the genes IDS, TRBV18, CCDC22, RPS26, and MTUS2-AS1, which one exhibits the highest specificity for myeloid dendritic cells, thereby representing the most promising target for rheumatoid arthritis intervention? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in myeloid dendritic cells in the PINNACLE dataset. Calculate the average embedding of this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CTDNEP1', 'NCBP2L', 'MAMDC2-AS1', 'M1AP', 'LTB']",rheumatoid arthritis,myeloid dendritic cell,LTB,"Among the genes CTDNEP1, NCBP2L, MAMDC2-AS1, M1AP, and LTB, which one exhibits the highest cell-type specificity in myeloid dendritic cells for potential therapeutic targeting in rheumatoid arthritis?","Among the genes CTDNEP1, NCBP2L, MAMDC2-AS1, M1AP, and LTB, which one exhibits the highest cell-type specificity in myeloid dendritic cells for potential therapeutic targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with genes activated in myeloid dendritic cells. For the overlapping genes, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHLD3', 'HLA-E', 'INSIG1', 'WDR35', 'ATG12']",rheumatoid arthritis,myeloid dendritic cell,HLA-E,"Among the genes SHLD3, HLA-E, INSIG1, WDR35, and ATG12, which one exhibits the most specific expression in myeloid dendritic cells for potential targeting in rheumatoid arthritis?","Among the genes SHLD3, HLA-E, INSIG1, WDR35, and ATG12, which one exhibits the most specific expression in myeloid dendritic cells for potential targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes activated in myeloid dendritic cells as recorded in PINNACLE. For the overlapping genes, calculate the average embedding and compute the cosine similarity between this average and each individual gene’s embedding. If one gene displays a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NUDT5', 'TAPBPL', 'COX4I1', 'DPH1', 'ZFAT-AS1']",rheumatoid arthritis,myeloid dendritic cell,COX4I1,"Which gene among NUDT5, TAPBPL, COX4I1, DPH1, and ZFAT-AS1 demonstrates the greatest specificity for myeloid dendritic cells, thereby representing the most promising candidate for targeted interventions in rheumatoid arthritis?","Which gene among NUDT5, TAPBPL, COX4I1, DPH1, and ZFAT-AS1 demonstrates the greatest specificity for myeloid dendritic cells, thereby representing the most promising candidate for targeted interventions in rheumatoid arthritis? Identify the validated therapeutic gene targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in myeloid dendritic cells in PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['BARX2', 'CDR2L', 'ACTB', 'RAI2', 'CCDC71L']",rheumatoid arthritis,myeloid dendritic cell,ACTB,"Among the genes BARX2, CDR2L, ACTB, RAI2, and CCDC71L, which one exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes BARX2, CDR2L, ACTB, RAI2, and CCDC71L, which one exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets are also present in the myeloid dendritic cell–activated gene set from PINNACLE, and compute the average embedding for this overlapping set. Calculate the cosine similarity between the average embedding and each individual target embedding; if one gene exhibits a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['UBE2W', 'TRIM3', 'BPTF', 'RPLP1', 'SLC41A2']",rheumatoid arthritis,myeloid dendritic cell,RPLP1,"Among UBE2W, TRIM3, BPTF, RPLP1, and SLC41A2, which gene exhibits the highest cell‐type specificity in myeloid dendritic cells as a candidate target for rheumatoid arthritis?","Among UBE2W, TRIM3, BPTF, RPLP1, and SLC41A2, which gene exhibits the highest cell‐type specificity in myeloid dendritic cells as a candidate target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the myeloid dendritic cell–activated genes available in PINNACLE to define a cell-type–specific target set. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CD52', 'NPIPB3', 'COPS7B', 'LINC01206', 'NUP85']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Among the genes CD52, NPIPB3, COPS7B, LINC01206, and NUP85, which one demonstrates the highest cell-type specificity in myeloid dendritic cells for therapeutic targeting in rheumatoid arthritis?","Among the genes CD52, NPIPB3, COPS7B, LINC01206, and NUP85, which one demonstrates the highest cell-type specificity in myeloid dendritic cells for therapeutic targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in myeloid dendritic cells within the PINNACLE dataset to obtain a set of cell-type–specific RA targets. Compute the average embedding for this set to serve as a reference vector, and then calculate the cosine similarity between this reference and the embedding of each target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['C22orf15', 'ACTB', 'LINC00683', 'R3HDM4', 'NADSYN1']",rheumatoid arthritis,myeloid dendritic cell,ACTB,"Which gene among C22orf15, ACTB, LINC00683, R3HDM4, and NADSYN1 exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis?","Which gene among C22orf15, ACTB, LINC00683, R3HDM4, and NADSYN1 exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis? Identify the set of verified therapeutic targets for rheumatoid arthritis with available cell-type–specific embeddings in PINNACLE, and determine which of these targets overlap with myeloid dendritic cell-activated genes. Calculate the average embedding of the overlapping genes as a reference and then compute the cosine similarity between this reference and each individual target embedding. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LILRA4', 'WDR86', 'LINC02201', 'ACTB', 'KLHL3']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,ACTB,"Which gene among LILRA4, WDR86, LINC02201, ACTB, and KLHL3 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most suitable candidate for targeting rheumatoid arthritis?","Which gene among LILRA4, WDR86, LINC02201, ACTB, and KLHL3 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most suitable candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in naive thymus-derived CD8+ alpha-beta T cells overlap with these targets, thereby defining the cell-type–specific targets in rheumatoid arthritis. Compute the average embedding of this overlapping gene set to serve as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['YPEL2', 'ATXN7L3B', 'DCAF5', 'NFKBIA', 'B4GALNT3']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,NFKBIA,"Which gene among YPEL2, ATXN7L3B, DCAF5, NFKBIA, and B4GALNT3 demonstrates the highest cell-type specific expression in naive thymus-derived CD8+ αβ T cells, thereby representing the optimal target for rheumatoid arthritis intervention?","Which gene among YPEL2, ATXN7L3B, DCAF5, NFKBIA, and B4GALNT3 demonstrates the highest cell-type specific expression in naive thymus-derived CD8+ αβ T cells, thereby representing the optimal target for rheumatoid arthritis intervention? Retrieve the verified therapeutic targets for rheumatoid arthritis from PINNACLE and extract their cell-type–specific embeddings. Next, identify the overlap between these targets and the naive thymus-derived CD8+ alpha-beta T cell activation genes available in PINNACLE; this overlapping set represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this subset and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['S100A10', 'LINC02397', 'IDE', 'LINC00683', 'FYTTD1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,S100A10,"Among the genes S100A10, LINC02397, IDE, LINC00683, and FYTTD1, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis?","Among the genes S100A10, LINC02397, IDE, LINC00683, and FYTTD1, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis? Identify all validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which genes associated with naive thymus-derived CD8+ alpha-beta T cell activation in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CLASP2', 'CACNA1D', 'ZNF112', 'EFCAB6-DT', 'HLA-C']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,HLA-C,"Which gene among CLASP2, CACNA1D, ZNF112, EFCAB6-DT, and HLA-C exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis intervention?","Which gene among CLASP2, CACNA1D, ZNF112, EFCAB6-DT, and HLA-C exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis intervention? Identify the verified therapeutic targets for rheumatoid arthritis with available cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in naive, thymus-derived CD8+ αβ T cells. For this overlapping set, compute the average embedding and calculate the cosine similarity between this reference and the individual gene embeddings. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['N6AMT1', 'LINC01931', 'TSPAN17', 'ZBTB25', 'RPL21']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPL21,"Which gene among N6AMT1, LINC01931, TSPAN17, ZBTB25, and RPL21 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells relative to rheumatoid arthritis?","Which gene among N6AMT1, LINC01931, TSPAN17, ZBTB25, and RPL21 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells relative to rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis in PINNACLE and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the set of naive, thymus-derived CD8+ αβ T cell–activated genes in PINNACLE. Compute the average embedding for the overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANAPC16', 'LTB', 'XXYLT1', 'ERGIC3', 'EI24']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,LTB,"Among the genes ANAPC16, LTB, XXYLT1, ERGIC3, and EI24, which one exhibits the highest specificity for naïve thymus-derived CD8+ αβ T cells and represents the most promising candidate for targeting rheumatoid arthritis?","Among the genes ANAPC16, LTB, XXYLT1, ERGIC3, and EI24, which one exhibits the highest specificity for naïve thymus-derived CD8+ αβ T cells and represents the most promising candidate for targeting rheumatoid arthritis? Determine the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, from the PINNACLE dataset for naive thymus-derived CD8+ alpha-beta T cells, identify the genes that overlap with these targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['RPLP1', 'WASF3-AS1', 'PGAM5', 'CCT7', 'TFE3']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPLP1,"Among the genes RPLP1, WASF3-AS1, PGAM5, CCT7, and TFE3, which one demonstrates the highest cell-type specificity in naive thymus‐derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention?","Among the genes RPLP1, WASF3-AS1, PGAM5, CCT7, and TFE3, which one demonstrates the highest cell-type specificity in naive thymus‐derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Determine which targets overlap with the naive thymus–derived CD8+ αβ T-cell–activated gene set in PINNACLE, as this overlapping set represents the cell-type–specific targets for the disease. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target. If one target shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SAA2', 'FARSA', 'DNMBP', 'FOS', 'ELMO3']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,FOS,"Among the genes SAA2, FARSA, DNMBP, FOS, and ELMO3, which one exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Among the genes SAA2, FARSA, DNMBP, FOS, and ELMO3, which one exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis? Determine the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the genes associated with naive thymus-derived CD8+ αβ T cell activation in PINNACLE. Within this overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual gene target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF155', 'TCEA2', 'RPS26', 'SNX12', 'SLC26A11']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPS26,"Which gene among ZNF155, TCEA2, RPS26, SNX12, and SLC26A11 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells as a potential target for rheumatoid arthritis?","Which gene among ZNF155, TCEA2, RPS26, SNX12, and SLC26A11 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells as a potential target for rheumatoid arthritis? For validated rheumatoid arthritis therapeutic targets, retrieve their cell-type–specific embeddings from the PINNACLE database. Identify the overlap between these targets and the genes activated in naive thymus-derived CD8+ αβ T cells as recorded in PINNACLE, and define this intersection as the set of cell-type–specific targets. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this average vector and each individual target gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM143', 'LMBR1L', 'LSR', 'MT-ND3', 'BACH1-IT2']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND3,"Which gene, among TMEM143, LMBR1L, LSR, MT-ND3, and BACH1-IT2, exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting rheumatoid arthritis?","Which gene, among TMEM143, LMBR1L, LSR, MT-ND3, and BACH1-IT2, exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes—originally activated in naive, thymus-derived CD8+ αβ T cells—overlap with these targets to define a set of cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of these overlapping genes as a reference point, then compute the cosine similarity between this reference and each individual target embedding. Finally, if one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXO41', 'RNF13', 'ZC3H18', 'CCDC85B', 'RPL3']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPL3,"Which gene among FBXO41, RNF13, ZC3H18, CCDC85B, and RPL3 exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells to serve as a promising target for rheumatoid arthritis?","Which gene among FBXO41, RNF13, ZC3H18, CCDC85B, and RPL3 exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells to serve as a promising target for rheumatoid arthritis? Identify the therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of naive, thymus-derived CD8+ αβ T cell-activated genes in PINNACLE. Calculate the average embedding of this overlapping set to use as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NT5DC1', 'RNASEH2B-AS1', 'CALHM6', 'VIPAS39', 'DDX6']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,DDX6,"Among the genes NT5DC1, RNASEH2B-AS1, CALHM6, VIPAS39, and DDX6, which exhibits the highest specificity for naive thymus-derived CD8+ αβ T cells, thereby representing the most promising candidate for targeted intervention in rheumatoid arthritis?","Among the genes NT5DC1, RNASEH2B-AS1, CALHM6, VIPAS39, and DDX6, which exhibits the highest specificity for naive thymus-derived CD8+ αβ T cells, thereby representing the most promising candidate for targeted intervention in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in naive thymus-derived CD8+ αβ T cells from PINNACLE. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CD52', 'UBA5', 'EXOC3', 'RGS1', 'LINC02315']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,CD52,"Which gene among CD52, UBA5, EXOC3, RGS1, and LINC02315 exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis therapy?","Which gene among CD52, UBA5, EXOC3, RGS1, and LINC02315 exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in naive thymus-derived CD8+ αβ T cells as recorded in PINNACLE. For the overlapping gene set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TBC1D8B', 'ZNF623', 'PPP1CB', 'MT-ND6', 'MFN1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND6,"Among the genes TBC1D8B, ZNF623, PPP1CB, MT-ND6, and MFN1, which one exhibits the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells, making it the optimal candidate for targeting rheumatoid arthritis?","Among the genes TBC1D8B, ZNF623, PPP1CB, MT-ND6, and MFN1, which one exhibits the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells, making it the optimal candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes expressed in naïve, thymus-derived, CD8-positive alpha beta T cells upon activation, as annotated in PINNACLE. Compute the average embedding for the overlapping genes, then calculate the cosine similarity between this reference and each target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIR2DL4', 'LINC01781', 'CDC42SE2', 'NFKBIA', 'FHL1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,NFKBIA,"Which gene—KIR2DL4, LINC01781, CDC42SE2, NFKBIA, or FHL1—demonstrates the highest cell-type specificity in naive thymus‐derived CD8+ alpha-beta T cells for targeting rheumatoid arthritis?","Which gene—KIR2DL4, LINC01781, CDC42SE2, NFKBIA, or FHL1—demonstrates the highest cell-type specificity in naive thymus‐derived CD8+ alpha-beta T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD8+ αβ T cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type-specific RA targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WASHC3', 'FBXO3', 'RPL21', 'GLO1', 'PPME1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPL21,"Which gene—WASHC3, FBXO3, RPL21, GLO1, or PPME1—displays the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting rheumatoid arthritis?","Which gene—WASHC3, FBXO3, RPL21, GLO1, or PPME1—displays the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived, CD8+ alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set for rheumatoid arthritis. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYB561D1', 'POLR2E', 'ETV6', 'RPS26', 'ADHFE1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPS26,"Which gene among CYB561D1, POLR2E, ETV6, RPS26, and ADHFE1 exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among CYB561D1, POLR2E, ETV6, RPS26, and ADHFE1 exhibits the highest specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis? Retrieve the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in naive thymus-derived CD8+ αβ T cells as identified in PINNACLE. For the overlapping gene set, compute an average embedding to serve as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C19orf67', 'PIGBOS1', 'CNEP1R1', 'MT-ND3', 'MPDZ']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND3,"Which gene among C19orf67, PIGBOS1, CNEP1R1, MT-ND3, and MPDZ exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among C19orf67, PIGBOS1, CNEP1R1, MT-ND3, and MPDZ exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with genes associated with naive thymus-derived CD8+ alpha-beta T cell activation in PINNACLE, thereby defining the cell-type–specific RA targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LTB', 'LINC02536', 'FBXO44', 'EPB41L1', 'TOE1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,LTB,"Which gene—LTB, LINC02536, FBXO44, EPB41L1, or TOE1—exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, and therefore represents the most promising target for rheumatoid arthritis interventions?","Which gene—LTB, LINC02536, FBXO44, EPB41L1, or TOE1—exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, and therefore represents the most promising target for rheumatoid arthritis interventions? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes from the naive thymus-derived CD8+ alpha-beta T cell activation set overlap with these RA targets, thereby defining the cell-type–specific targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in RA."
"['TBRG4', 'S100A10', 'MBLAC1', 'CENPI', 'RNF168']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,S100A10,"Which gene among TBRG4, S100A10, MBLAC1, CENPI, and RNF168 shows the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among TBRG4, S100A10, MBLAC1, CENPI, and RNF168 shows the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes in the PINNACLE dataset—associated with naive thymus-derived CD8+ αβ T cell activation—overlap with these targets. Compute the average embedding for the overlapping genes to establish a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SULT1A3', 'RNF111', 'RPS26', 'MICOS13', 'CHRNB1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPS26,"Among the genes SULT1A3, RNF111, RPS26, MICOS13, and CHRNB1, which one displays the greatest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis?","Among the genes SULT1A3, RNF111, RPS26, MICOS13, and CHRNB1, which one displays the greatest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis? Identify all validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD4+ αβ T cell activation genes in PINNACLE to define the subset of cell-type–specific RA targets. Compute the average embedding for this subset and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a notably higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCDC110', 'TTLL9', 'DGKH', 'FAM174A', 'COX4I1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,COX4I1,"Which gene among CCDC110, TTLL9, DGKH, FAM174A, and COX4I1 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among CCDC110, TTLL9, DGKH, FAM174A, and COX4I1 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of naïve, thymus-derived, CD4-positive, alpha-beta T cell–activated genes from PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this mean embedding and each individual target embedding. If one gene exhibits a significantly higher cosine similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['RPL3', 'TMEM158', 'FNDC7', 'MINPP1', 'CHSY3']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPL3,"Among the genes RPL3, TMEM158, FNDC7, MINPP1, and CHSY3, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes RPL3, TMEM158, FNDC7, MINPP1, and CHSY3, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis using PINNACLE and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with the genes activated in naive thymus-derived CD4+ αβ T cells captured in PINNACLE. For the overlapping set, calculate the average embedding and compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IKZF1', 'REXO1', 'C18orf21', 'FBH1', 'ANKRD30B']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,IKZF1,"Which gene among IKZF1, REXO1, C18orf21, FBH1, and ANKRD30B shows the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the best candidate for targeting rheumatoid arthritis?","Which gene among IKZF1, REXO1, C18orf21, FBH1, and ANKRD30B shows the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the best candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Retrieve the gene set corresponding to activated, naive thymus–derived CD4⁺ αβ T cells from PINNACLE, and determine the overlap with the rheumatoid arthritis targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL21', 'H2BC4', 'NAE1', 'SLIT3', 'GEMIN2']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPL21,"Which gene among RPL21, H2BC4, NAE1, SLIT3, and GEMIN2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis?","Which gene among RPL21, H2BC4, NAE1, SLIT3, and GEMIN2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis? Using the PINNACLE database, identify validated therapeutic targets for rheumatoid arthritis and extract their corresponding cell-type–specific embeddings. Next, determine which of these targets overlap with the naive thymus-derived CD4+ αβ T-cell activation genes in PINNACLE, thereby defining the cell-type–specific RA targets. Calculate the average embedding of these overlapping genes and compute the cosine similarity between this reference vector and the embedding of each target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BRCA2', 'TNFAIP3', 'C2orf88', 'VCAN-AS1', 'TPRN']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,TNFAIP3,"Which gene among BRCA2, TNFAIP3, C2orf88, VCAN-AS1, and TPRN exhibits the highest cell-type specificity in naïve thymus-derived CD4⁺ αβ T cells, making it the best candidate for targeting rheumatoid arthritis?","Which gene among BRCA2, TNFAIP3, C2orf88, VCAN-AS1, and TPRN exhibits the highest cell-type specificity in naïve thymus-derived CD4⁺ αβ T cells, making it the best candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes linked to naive thymus-derived CD4+ αβ T cell activation in PINNACLE overlap with these targets to define a cell-type–specific target set. Compute the average embedding of this overlapping group as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASMTL_ENSG00000169093', 'DDX6', 'UPK3BL1', 'ANGPTL1', 'ACTR10']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,DDX6,"Which gene among ASMTL_ENSG00000169093, DDX6, UPK3BL1, ANGPTL1, and ACTR10 exhibits the highest cell-type specificity in naïve thymus-derived CD4+αβ T cells for targeting rheumatoid arthritis?","Which gene among ASMTL_ENSG00000169093, DDX6, UPK3BL1, ANGPTL1, and ACTR10 exhibits the highest cell-type specificity in naïve thymus-derived CD4+αβ T cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the naive thymus-derived CD4+ αβ T cell activation gene set from PINNACLE. Compute the average embedding of these overlapping genes, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SHROOM3', 'LY6E-DT', 'RBBP6', 'ACTB', 'MCRS1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,ACTB,"Which gene—SHROOM3, LY6E-DT, RBBP6, ACTB, or MCRS1—exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, indicating its potential as a targeted therapeutic for rheumatoid arthritis?","Which gene—SHROOM3, LY6E-DT, RBBP6, ACTB, or MCRS1—exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, indicating its potential as a targeted therapeutic for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the activated genes from naive thymus-derived CD4⁺ alpha-beta T cells in PINNACLE, thereby defining the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set, and then calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MTHFD1', 'AP1S1', 'APC', 'CLEC18B', 'RPLP1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPLP1,"Which of the following genes—MTHFD1, AP1S1, APC, CLEC18B, or RPLP1—exhibits the highest cell-type-specific expression in naïve thymus-derived CD4+ αβ T cells, making it the best candidate for targeted rheumatoid arthritis intervention?","Which of the following genes—MTHFD1, AP1S1, APC, CLEC18B, or RPLP1—exhibits the highest cell-type-specific expression in naïve thymus-derived CD4+ αβ T cells, making it the best candidate for targeted rheumatoid arthritis intervention? Using the PINNACLE dataset, first identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the gene set associated with naive thymus-derived CD4+ alpha-beta T cell activation. This overlapping set represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['URB2', 'RNF2', 'TRA2A', 'SESN3', 'MAPKAP1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,SESN3,"Among the following genes—URB2, RNF2, TRA2A, SESN3, and MAPKAP1—which one demonstrates the highest specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis therapy?","Among the following genes—URB2, RNF2, TRA2A, SESN3, and MAPKAP1—which one demonstrates the highest specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis from PINNACLE and obtain their cell-type–specific embeddings. Next, determine which genes from PINNACLE's naive thymus–derived CD4⁺ alpha-beta T cell activation set overlap with these targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND3', 'FLJ20021', 'MYOCOS', 'LINC01934', 'LINC01044']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,MT-ND3,"Which gene among MT-ND3, FLJ20021, MYOCOS, LINC01934, and LINC01044 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis?","Which gene among MT-ND3, FLJ20021, MYOCOS, LINC01934, and LINC01044 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which genes activated in naive thymus-derived CD4-positive αβ T cells (as identified in PINNACLE) overlap with these therapeutic targets. Compute the average embedding for the overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LTB', 'CAPRIN2', 'ZBTB24', 'TERC', 'TRIM10']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,LTB,"Among LTB, CAPRIN2, ZBTB24, TERC, and TRIM10, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, indicating its potential as the prime candidate for targeted interventions in rheumatoid arthritis?","Among LTB, CAPRIN2, ZBTB24, TERC, and TRIM10, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, indicating its potential as the prime candidate for targeted interventions in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus–derived CD4+ αβ T cell activation gene set in PINNACLE to define the RA-specific cell-type targets. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF213', 'GAPLINC', 'HLA-E', 'NAGPA', 'APBB1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,HLA-E,"Among the genes ZNF213, GAPLINC, HLA-E, NAGPA, and APBB1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes ZNF213, GAPLINC, HLA-E, NAGPA, and APBB1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the naive thymus-derived CD4+ αβ T cell–activated genes within PINNACLE overlap with these targets to define a cell-type–specific target set. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPP6R3', 'LIPG', 'RGPD6', 'KCTD21', 'CD52']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,CD52,"Which gene, among PPP6R3, LIPG, RGPD6, KCTD21, and CD52, exhibits the highest cell-type specificity in naive thymus-derived CD4⁺ αβ T cells for targeting rheumatoid arthritis?","Which gene, among PPP6R3, LIPG, RGPD6, KCTD21, and CD52, exhibits the highest cell-type specificity in naive thymus-derived CD4⁺ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell type–specific embeddings from PINNACLE. Next, determine which genes activated in naive, thymus-derived CD4+ αβ T cells overlap with these targets. Compute the average embedding of the overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene displays substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EDN2', 'TSSK6', 'TMEM120A', 'NUFIP1', 'PTPRC']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,PTPRC,"Among the genes EDN2, TSSK6, TMEM120A, NUFIP1, and PTPRC, which exhibits the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis intervention?","Among the genes EDN2, TSSK6, TMEM120A, NUFIP1, and PTPRC, which exhibits the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis intervention? Identify the validated rheumatoid arthritis therapeutic targets in PINNACLE and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the naive thymus-derived, CD4+ alpha-beta T cell–activated gene signatures in PINNACLE. Compute the average embedding of the overlapping genes and then calculate the cosine similarity between this reference embedding and each target’s embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FECH', 'DDN', 'ZBTB33', 'CPNE9', 'RPLP1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPLP1,"Among the genes FECH, DDN, ZBTB33, CPNE9, and RPLP1, which one shows the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes FECH, DDN, ZBTB33, CPNE9, and RPLP1, which one shows the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Retrieve the cell-type-specific embeddings from PINNACLE for verified therapeutic targets of rheumatoid arthritis. Identify the intersection between these targets and the naive thymus-derived, CD4-positive, alpha-beta T cell-activated genes within PINNACLE. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene demonstrates a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to rheumatoid arthritis."
"['SH2D5', 'SLC35A5', 'GTF2F1', 'BORCS5', 'RPS26']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPS26,"Which gene among SH2D5, SLC35A5, GTF2F1, BORCS5, and RPS26 exhibits the highest cell-type-specific expression in naive thymus-derived CD4+ αβ T cells, indicating its potential as the best candidate target for rheumatoid arthritis?","Which gene among SH2D5, SLC35A5, GTF2F1, BORCS5, and RPS26 exhibits the highest cell-type-specific expression in naive thymus-derived CD4+ αβ T cells, indicating its potential as the best candidate target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis in the PINNACLE database and retrieve their cell-type–specific embeddings. Next, determine the overlap between these targets and the naive thymus-derived CD4+ αβ T cell activation gene set from PINNACLE; this overlapping subset represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between the reference and each individual target. Finally, if one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PCAT1', 'PTPRC', 'TRBV16', 'PRKCZ-AS1', 'ESM1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,PTPRC,"Which gene among PCAT1, PTPRC, TRBV16, PRKCZ-AS1, and ESM1 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting rheumatoid arthritis?","Which gene among PCAT1, PTPRC, TRBV16, PRKCZ-AS1, and ESM1 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. From the naive thymus-derived CD4+ αβ T cell–activated genes in PINNACLE, determine which genes overlap with these targets to define a set of cell-type–specific rheumatoid arthritis targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each target’s embedding. If one gene displays a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SESN3', 'KLF2-DT', 'TBC1D24', 'FAM83H', 'C3orf62']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,SESN3,"Which gene among SESN3, KLF2‐DT, TBC1D24, FAM83H, and C3orf62 exhibits the highest cell-type-specific expression in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis?","Which gene among SESN3, KLF2‐DT, TBC1D24, FAM83H, and C3orf62 exhibits the highest cell-type-specific expression in naive thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis? Determine the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Identify the overlapping genes between these targets and the naive thymus–derived CD4+αβ T cell activation markers in PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['CLTA', 'SRD5A3', 'ABHD2', 'CYP51A1-AS1', 'HLA-E']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,HLA-E,"Among the genes CLTA, SRD5A3, ABHD2, CYP51A1-AS1, and HLA-E, which exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the optimal candidate for targeting rheumatoid arthritis?","Among the genes CLTA, SRD5A3, ABHD2, CYP51A1-AS1, and HLA-E, which exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the optimal candidate for targeting rheumatoid arthritis? Identify the validated therapeutic target genes for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection of these targets with the naive thymus-derived CD4+ αβ T cell–activated gene set in PINNACLE. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['LINC02724', 'MICOS13', 'APBA2', 'AKR7A3', 'FOS']",rheumatoid arthritis,natural killer cell,FOS,"Among the following genes—LINC02724, MICOS13, APBA2, AKR7A3, and FOS—which one exhibits the highest natural killer cell-specific expression, making it the most promising candidate for targeting in rheumatoid arthritis?","Among the following genes—LINC02724, MICOS13, APBA2, AKR7A3, and FOS—which one exhibits the highest natural killer cell-specific expression, making it the most promising candidate for targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis (RA) and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with natural killer cell-activated genes in PINNACLE to define the cell-type–specific RA targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in RA."
"['ACTB', 'TRBV11-2', 'SLC43A1', 'CYP2J2', 'SPP2']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene—ACTB, TRBV11-2, SLC43A1, CYP2J2, or SPP2—exhibits the highest natural killer cell-specific expression relevant to therapeutic targeting in rheumatoid arthritis?","Which gene—ACTB, TRBV11-2, SLC43A1, CYP2J2, or SPP2—exhibits the highest natural killer cell-specific expression relevant to therapeutic targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis in the PINNACLE dataset and obtain their cell type–specific embeddings. Next, determine which of these targets overlap with natural killer cell–activated genes in PINNACLE. Compute the average embedding of the overlapping set and calculate the cosine similarity between this average and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZFAND3', 'ZFP64', 'NFKBIA', 'POC1A', 'ZNF562']",rheumatoid arthritis,natural killer cell,NFKBIA,"Among the genes ZFAND3, ZFP64, NFKBIA, POC1A, and ZNF562, which exhibits the most selective expression in natural killer cells, making it the best candidate for targeted therapeutic interventions in rheumatoid arthritis?","Among the genes ZFAND3, ZFP64, NFKBIA, POC1A, and ZNF562, which exhibits the most selective expression in natural killer cells, making it the best candidate for targeted therapeutic interventions in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the genes activated in natural killer cells as recorded in PINNACLE; this overlapping gene set represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for these genes and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['JAK1', 'NHEJ1', 'KLHL18', 'PAOX', 'C16orf74']",rheumatoid arthritis,natural killer cell,JAK1,"Which gene among JAK1, NHEJ1, KLHL18, PAOX, and C16orf74 exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among JAK1, NHEJ1, KLHL18, PAOX, and C16orf74 exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the natural killer cell–activated genes in PINNACLE to define a set of cell-type–specific rheumatoid arthritis targets. Compute the average embedding of this set to serve as a reference vector, then calculate the cosine similarity between this reference and the embedding for each individual target. If one gene displays a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KCTD6', 'FOXN3-AS2', 'PPP3R1', 'ACAA2', 'HLA-C']",rheumatoid arthritis,natural killer cell,HLA-C,"Which gene among KCTD6, FOXN3-AS2, PPP3R1, ACAA2, and HLA-C exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among KCTD6, FOXN3-AS2, PPP3R1, ACAA2, and HLA-C exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the natural killer cell-activated genes in PINNACLE. For the overlapping set, compute their average embedding, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACTB', 'SEPSECS', 'ZSWIM9', 'LINC01623', 'GABRR2']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene among ACTB, SEPSECS, ZSWIM9, LINC01623, and GABRR2 exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeted rheumatoid arthritis therapy?","Which gene among ACTB, SEPSECS, ZSWIM9, LINC01623, and GABRR2 exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeted rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their corresponding cell‐type–specific embeddings from the PINNACLE database. Then, determine which targets overlap with genes activated in natural killer cells in PINNACLE to define the RA cell-type–specific targets. Next, calculate the average embedding for this overlapping set and compute the cosine similarity between this reference embedding and each individual target. Finally, if one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-C', 'TECTA', 'ZNF324B', 'GREM1', 'ANKMY1']",rheumatoid arthritis,natural killer cell,HLA-C,"Among the genes HLA-C, TECTA, ZNF324B, GREM1, and ANKMY1, which exhibits the greatest natural killer cell specificity for targeting rheumatoid arthritis?","Among the genes HLA-C, TECTA, ZNF324B, GREM1, and ANKMY1, which exhibits the greatest natural killer cell specificity for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which natural killer cell–activated genes in PINNACLE intersect with these targets, defining the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, designate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['ZNF441', 'PLPP6', 'ATP8B1', 'FOS', 'GAL3ST1']",rheumatoid arthritis,natural killer cell,FOS,"Which gene among ZNF441, PLPP6, ATP8B1, FOS, and GAL3ST1 exhibits the highest cell-type-specific expression in natural killer cells for targeting rheumatoid arthritis?","Which gene among ZNF441, PLPP6, ATP8B1, FOS, and GAL3ST1 exhibits the highest cell-type-specific expression in natural killer cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis, and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, identify which genes activated in natural killer cells in PINNACLE overlap with these targets to determine the cell-type-specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set, and calculate the cosine similarity between this average and the embedding for each target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01786', 'LDLRAP1', 'JAK1', 'CNOT7', 'SEC61G']",rheumatoid arthritis,natural killer cell,JAK1,"Which gene among LINC01786, LDLRAP1, JAK1, CNOT7, and SEC61G exhibits the highest specificity to natural killer cells for the potential targeting of rheumatoid arthritis?","Which gene among LINC01786, LDLRAP1, JAK1, CNOT7, and SEC61G exhibits the highest specificity to natural killer cells for the potential targeting of rheumatoid arthritis? Using verified therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the natural killer cell–activated genes in PINNACLE to define a set of cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this intersecting set and calculate the cosine similarity between this average reference and each individual target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MAN2B1', 'ENSA', 'NFKBIA', 'MAST3-AS1', 'ECI2-DT']",rheumatoid arthritis,natural killer cell,NFKBIA,"Among the genes MAN2B1, ENSA, NFKBIA, MAST3-AS1, and ECI2-DT, which one exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeting rheumatoid arthritis?","Among the genes MAN2B1, ENSA, NFKBIA, MAST3-AS1, and ECI2-DT, which one exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the natural killer cell–activated genes listed in PINNACLE to define a set of cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HNRNPM', 'JAK1', 'RBCK1', 'CAVIN2-AS1', 'DNASE2']",rheumatoid arthritis,natural killer cell,JAK1,"Among the following genes—HNRNPM, JAK1, RBCK1, CAVIN2-AS1, and DNASE2—which one exhibits the highest cell-type specificity in natural killer cells concerning its potential role in rheumatoid arthritis?","Among the following genes—HNRNPM, JAK1, RBCK1, CAVIN2-AS1, and DNASE2—which one exhibits the highest cell-type specificity in natural killer cells concerning its potential role in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with natural killer cell–activated genes from the same dataset. Calculate the average embedding of the overlapping genes, then compute the cosine similarity between this average and each target’s individual embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM98', 'FOS', 'TMEM121', 'PYGB', 'CCDC89']",rheumatoid arthritis,natural killer cell,FOS,"Among the genes TMEM98, FOS, TMEM121, PYGB, and CCDC89, which one exhibits the highest cell-type specificity in natural killer cells as a promising target for rheumatoid arthritis intervention?","Among the genes TMEM98, FOS, TMEM121, PYGB, and CCDC89, which one exhibits the highest cell-type specificity in natural killer cells as a promising target for rheumatoid arthritis intervention? Identify the confirmed therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which natural killer cell–activated gene embeddings in PINNACLE overlap with those targets, forming the cell-type–specific target set. Compute the average embedding of this set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the best candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HLA-C', 'DDX25', 'UCA1', 'DMBX1', 'GTSF1L']",rheumatoid arthritis,natural killer cell,HLA-C,"Which gene among HLA-C, DDX25, UCA1, DMBX1, and GTSF1L exhibits the highest specificity for natural killer cells, making it the most promising target for rheumatoid arthritis therapy?","Which gene among HLA-C, DDX25, UCA1, DMBX1, and GTSF1L exhibits the highest specificity for natural killer cells, making it the most promising target for rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, from the natural killer cell-activated genes in PINNACLE, determine which ones overlap with these targets to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the individual embeddings. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRKN', 'MAK16', 'USP35', 'ACTB', 'ACAA2']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene among PRKN, MAK16, USP35, ACTB, and ACAA2 exhibits the highest specificity of expression in natural killer cells, making it the most promising candidate for targeting in rheumatoid arthritis?","Which gene among PRKN, MAK16, USP35, ACTB, and ACAA2 exhibits the highest specificity of expression in natural killer cells, making it the most promising candidate for targeting in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the natural killer cell–activated genes in PINNACLE, forming a set of cell-type–specific targets for the disease. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate this gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NUP93-DT', 'TAF1A', 'NFKBIA', 'RBM34', 'ITGA9']",rheumatoid arthritis,natural killer cell,NFKBIA,"Among the genes NUP93-DT, TAF1A, NFKBIA, RBM34, and ITGA9, which one exhibits the greatest cell-type specificity in natural killer cells and holds the most promise as a target for rheumatoid arthritis therapy?","Among the genes NUP93-DT, TAF1A, NFKBIA, RBM34, and ITGA9, which one exhibits the greatest cell-type specificity in natural killer cells and holds the most promise as a target for rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine the intersection with the natural killer cell-activated genes in PINNACLE to yield the cell-type-specific RA targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LIPE-AS1', 'ACTB', 'CRACD', 'AP2A2', 'S100A5']",rheumatoid arthritis,natural killer cell,ACTB,"Among the genes LIPE-AS1, ACTB, CRACD, AP2A2, and S100A5, which one exhibits the highest cell-type specificity within natural killer cells for potential targeting in rheumatoid arthritis therapy?","Among the genes LIPE-AS1, ACTB, CRACD, AP2A2, and S100A5, which one exhibits the highest cell-type specificity within natural killer cells for potential targeting in rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, identify the subset of natural killer cell–activated genes in PINNACLE that overlap with these targets. Calculate the average embedding for these overlapping genes, then compute the cosine similarity between this average embedding and the embedding of each gene. If a single gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-C', 'JMJD4', 'TSPYL6', 'ZNF667', 'RAB3D']",rheumatoid arthritis,natural killer cell,HLA-C,"Which gene among HLA-C, JMJD4, TSPYL6, ZNF667, and RAB3D exhibits the highest natural killer cell specificity relevant to targeting rheumatoid arthritis?","Which gene among HLA-C, JMJD4, TSPYL6, ZNF667, and RAB3D exhibits the highest natural killer cell specificity relevant to targeting rheumatoid arthritis? Using the verified therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from PINNACLE. Next, identify which targets overlap with the natural killer cell–activated genes in PINNACLE to define the rheumatoid arthritis cell-type–specific targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference embedding and the embedding of each individual target. Finally, if one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['ADAMTS6', 'CHRM3', 'FOS', 'LINC02241', 'SRRM2']",rheumatoid arthritis,natural killer cell,FOS,"Which gene among ADAMTS6, CHRM3, FOS, LINC02241, and SRRM2 demonstrates the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among ADAMTS6, CHRM3, FOS, LINC02241, and SRRM2 demonstrates the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlapping set between these targets and the genes activated in natural killer cells, and compute the average embedding for this set. Then, calculate the cosine similarity between each gene's embedding and this reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological significance."
"['CRIM1-DT', 'LCMT2', 'ATR', 'ZNF565', 'NFKBIA']",rheumatoid arthritis,natural killer cell,NFKBIA,"Among the genes CRIM1-DT, LCMT2, ATR, ZNF565, and NFKBIA, which one exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Among the genes CRIM1-DT, LCMT2, ATR, ZNF565, and NFKBIA, which one exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes from PINNACLE associated with natural killer cell activation overlap with these targets, thereby defining the NK cell–specific rheumatoid arthritis targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['JAK1', 'HACD1', 'OMG', 'HYAL1', 'ZNF585B']",rheumatoid arthritis,natural killer cell,JAK1,"Among the genes JAK1, HACD1, OMG, HYAL1, and ZNF585B, which shows the highest natural killer cell specificity for potential targeting in rheumatoid arthritis?","Among the genes JAK1, HACD1, OMG, HYAL1, and ZNF585B, which shows the highest natural killer cell specificity for potential targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and natural killer cell-activated genes in PINNACLE to obtain a set of cell-type–specific targets. Compute the average embedding of this set and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
